Delivery Order SPE2DB22D1002-SPE2DB25FLBN5

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,316.28, is for the supply of Skyrizi 150 mg/mL prefilled pens, a specialty medication used to treat certain medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of July 19, 2024. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Skyrizi 150 mg/mL prefilled pen injector. The contract has a ceiling value of $26,404.07 and an ultimate completion date of September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML medication. The order has a ceiling value of $22,936.21 and a completion date of February 11, 2025. The contract is a Firm Fixed Price type, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Skyrizi, a prescription medication, with a ceiling value of $34,076.97 and a period of performance through April 2025. The contract is not set aside and was awarded as a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award, valued at $22,036.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Skyrizi 150 mg/ml pens, a medication used in the treatment of various medical conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. The contract does not have a set-aside designation, indicating it was competed...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Skyrizi 600 mg/10 ml vials, a specialty medication, with a ceiling value of $6,119.69 and a period of performance through April 2, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $101,599.03, is for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product, with a ceiling value of $22,814.81 and a performance period through March 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,221.57, is for the delivery of SKYRIZI 150 MG/ML PENML, a specialty medication. The contract has a performance period through March 13, 2025 and is a firm fixed-price type. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a $18,861.37 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Skyrizi 150 mg/ml pens, a specialty medication used for the treatment of certain medical conditions. The award is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FLBN5
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Skyrizi 150 mg/mL pre-filled pens, a medication used to treat certain medical conditions. The contract has a ceiling value of $14,061.53 and a performance period ending on May 1, 2025. It is a firm-fixed-price contract type. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to the Defense Health Agency, U.S. Coast Guard, and other government agencies.

Generated 7/30/25, 10:13 AM